1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Chemotherapy 1.2.3 Radiation Therapy 1.2.4 Others 1.3 Market by Application 1.3.1 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Ambulatory Surgical Centers 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Perspective (2017-2028) 2.2 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Growth Trends by Region 2.2.1 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Historic Market Size by Region (2017-2022) 2.2.3 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Forecasted Market Size by Region (2023-2028) 2.3 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Dynamics 2.3.1 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Industry Trends 2.3.2 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Drivers 2.3.3 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Challenges 2.3.4 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Players by Revenue 3.1.1 Global Top Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Players by Revenue (2017-2022) 3.1.2 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue 3.4 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Concentration Ratio 3.4.1 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue in 2021 3.5 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Key Players Head office and Area Served 3.6 Key Players Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product Solution and Service 3.7 Date of Enter into Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Breakdown Data by Type 4.1 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Historic Market Size by Type (2017-2022) 4.2 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Forecasted Market Size by Type (2023-2028) 5 Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Breakdown Data by Application 5.1 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Historic Market Size by Application (2017-2022) 5.2 Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size (2017-2028) 6.2 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type 6.2.1 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2017-2022) 6.2.2 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2023-2028) 6.2.3 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Type (2017-2028) 6.3 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application 6.3.1 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2017-2022) 6.3.2 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2023-2028) 6.3.3 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Application (2017-2028) 6.4 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country 6.4.1 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2017-2022) 6.4.2 North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size (2017-2028) 7.2 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type 7.2.1 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2017-2022) 7.2.2 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2023-2028) 7.2.3 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Type (2017-2028) 7.3 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application 7.3.1 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2017-2022) 7.3.2 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2023-2028) 7.3.3 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Application (2017-2028) 7.4 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country 7.4.1 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2017-2022) 7.4.2 Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size (2017-2028) 8.2 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type 8.2.1 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Type (2017-2028) 8.3 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application 8.3.1 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Application (2017-2028) 8.4 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Region 8.4.1 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size (2017-2028) 9.2 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type 9.2.1 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2017-2022) 9.2.2 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2023-2028) 9.2.3 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Type (2017-2028) 9.3 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application 9.3.1 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2017-2022) 9.3.2 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2023-2028) 9.3.3 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Application (2017-2028) 9.4 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country 9.4.1 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2017-2022) 9.4.2 Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size (2017-2028) 10.2 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type 10.2.1 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Type (2017-2028) 10.3 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application 10.3.1 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Application (2017-2028) 10.4 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country 10.4.1 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Details 11.1.2 Roche Business Overview 11.1.3 Roche Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Introduction 11.1.4 Roche Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) 11.1.5 Roche Recent Developments 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Introduction 11.2.4 Novartis Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) 11.2.5 Novartis Recent Developments 11.3 Seattle Genetics 11.3.1 Seattle Genetics Company Details 11.3.2 Seattle Genetics Business Overview 11.3.3 Seattle Genetics Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Introduction 11.3.4 Seattle Genetics Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) 11.3.5 Seattle Genetics Recent Developments 11.4 Merck 11.4.1 Merck Company Details 11.4.2 Merck Business Overview 11.4.3 Merck Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Introduction 11.4.4 Merck Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) 11.4.5 Merck Recent Developments 11.5 Bristol-Myers Squibb 11.5.1 Bristol-Myers Squibb Company Details 11.5.2 Bristol-Myers Squibb Business Overview 11.5.3 Bristol-Myers Squibb Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Introduction 11.5.4 Bristol-Myers Squibb Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) 11.5.5 Bristol-Myers Squibb Recent Developments 11.6 Genmab AS 11.6.1 Genmab AS Company Details 11.6.2 Genmab AS Business Overview 11.6.3 Genmab AS Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Introduction 11.6.4 Genmab AS Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) 11.6.5 Genmab AS Recent Developments 11.7 Takeda Pharmaceutical 11.7.1 Takeda Pharmaceutical Company Details 11.7.2 Takeda Pharmaceutical Business Overview 11.7.3 Takeda Pharmaceutical Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Introduction 11.7.4 Takeda Pharmaceutical Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) 11.7.5 Takeda Pharmaceutical Recent Developments 11.8 Eisai Co., Ltd. 11.8.1 Eisai Co., Ltd. Company Details 11.8.2 Eisai Co., Ltd. Business Overview 11.8.3 Eisai Co., Ltd. Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Introduction 11.8.4 Eisai Co., Ltd. Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) 11.8.5 Eisai Co., Ltd. Recent Developments 11.9 Cellerant Therapeutics 11.9.1 Cellerant Therapeutics Company Details 11.9.2 Cellerant Therapeutics Business Overview 11.9.3 Cellerant Therapeutics Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Introduction 11.9.4 Cellerant Therapeutics Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) 11.9.5 Cellerant Therapeutics Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Chemotherapy Table 3. Key Players of Radiation Therapy Table 4. Key Players of Others Table 5. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Region (2017-2022) Table 9. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Region (2023-2028) Table 11. Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Trends Table 12. Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Drivers Table 13. Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Challenges Table 14. Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Restraints Table 15. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue Share by Players (2017-2022) Table 17. Global Top Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment as of 2021) Table 18. Ranking of Global Top Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product Solution and Service Table 22. Date of Enter into Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue Market Share by Type (2017-2022) Table 26. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue Market Share by Type (2023-2028) Table 28. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue Share by Application (2017-2022) Table 30. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue Share by Application (2023-2028) Table 32. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2017-2022) & (US$ Million) Table 33. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2023-2028) & (US$ Million) Table 34. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2017-2022) & (US$ Million) Table 35. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2023-2028) & (US$ Million) Table 36. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 37. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 38. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2017-2022) & (US$ Million) Table 39. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2023-2028) & (US$ Million) Table 40. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2017-2022) & (US$ Million) Table 41. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2023-2028) & (US$ Million) Table 42. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 43. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 44. Asia Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2017-2022) & (US$ Million) Table 45. Asia Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2023-2028) & (US$ Million) Table 46. Asia Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2017-2022) & (US$ Million) Table 47. Asia Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2023-2028) & (US$ Million) Table 48. Asia Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Region (2017-2022) & (US$ Million) Table 49. Asia Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Region (2023-2028) & (US$ Million) Table 50. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2017-2022) & (US$ Million) Table 51. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2023-2028) & (US$ Million) Table 52. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2017-2022) & (US$ Million) Table 53. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2023-2028) & (US$ Million) Table 54. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 55. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 56. Middle East and Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 62. Roche Company Details Table 63. Roche Business Overview Table 64. Roche Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product Table 65. Roche Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) & (US$ Million) Table 66. Roche Recent Developments Table 67. Novartis Company Details Table 68. Novartis Business Overview Table 69. Novartis Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product Table 70. Novartis Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) & (US$ Million) Table 71. Novartis Recent Developments Table 72. Seattle Genetics Company Details Table 73. Seattle Genetics Business Overview Table 74. Seattle Genetics Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product Table 75. Seattle Genetics Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) & (US$ Million) Table 76. Seattle Genetics Recent Developments Table 77. Merck Company Details Table 78. Merck Business Overview Table 79. Merck Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product Table 80. Merck Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) & (US$ Million) Table 81. Merck Recent Developments Table 82. Bristol-Myers Squibb Company Details Table 83. Bristol-Myers Squibb Business Overview Table 84. Bristol-Myers Squibb Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product Table 85. Bristol-Myers Squibb Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) & (US$ Million) Table 86. Bristol-Myers Squibb Recent Developments Table 87. Genmab AS Company Details Table 88. Genmab AS Business Overview Table 89. Genmab AS Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product Table 90. Genmab AS Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) & (US$ Million) Table 91. Genmab AS Recent Developments Table 92. Takeda Pharmaceutical Company Details Table 93. Takeda Pharmaceutical Business Overview Table 94. Takeda Pharmaceutical Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product Table 95. Takeda Pharmaceutical Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) & (US$ Million) Table 96. Takeda Pharmaceutical Recent Developments Table 97. Eisai Co., Ltd. Company Details Table 98. Eisai Co., Ltd. Business Overview Table 99. Eisai Co., Ltd. Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product Table 100. Eisai Co., Ltd. Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) & (US$ Million) Table 101. Eisai Co., Ltd. Recent Developments Table 102. Cellerant Therapeutics Company Details Table 103. Cellerant Therapeutics Business Overview Table 104. Cellerant Therapeutics Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Product Table 105. Cellerant Therapeutics Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) & (US$ Million) Table 106. Cellerant Therapeutics Recent Developments Table 107. Research Programs/Design for This Report Table 108. Key Data Information from Secondary Sources Table 109. Key Data Information from Primary Sources List of Figures Figure 1. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Type: 2021 VS 2028 Figure 2. Chemotherapy Features Figure 3. Radiation Therapy Features Figure 4. Others Features Figure 5. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Application: 2021 VS 2028 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Ambulatory Surgical Centers Case Studies Figure 9. Others Case Studies Figure 10. Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Report Years Considered Figure 11. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Region: 2021 VS 2028 Figure 14. Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Share by Players in 2021 Figure 15. Global Top Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Revenue in 2021 Figure 17. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 18. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Market Share by Type (2017-2028) Figure 19. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Market Share by Application (2017-2028) Figure 20. North America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Share by Country (2017-2028) Figure 21. United States Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 24. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Market Share by Type (2017-2028) Figure 25. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Market Share by Application (2017-2028) Figure 26. Europe Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Share by Country (2017-2028) Figure 27. Germany Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. France Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. U.K. Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Italy Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Russia Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Nordic Countries Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 34. Asia Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Market Share by Type (2017-2028) Figure 35. Asia Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Market Share by Application (2017-2028) Figure 36. Asia Pacific Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Share by Region (2017-2028) Figure 37. China Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Japan Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. South Korea Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Southeast Asia Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. India Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Australia Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 43. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 44. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Market Share by Type (2017-2028) Figure 45. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Market Share by Application (2017-2028) Figure 46. Latin America Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Share by Country (2017-2028) Figure 47. Mexico Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Brazil Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 50. Middle East and Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Market Share by Type (2017-2028) Figure 51. Middle East and Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Market Share by Application (2017-2028) Figure 52. Middle East and Africa Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size Share by Country (2017-2028) Figure 53. Turkey Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. UAE Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Roche Revenue Growth Rate in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) Figure 57. Novartis Revenue Growth Rate in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) Figure 58. Seattle Genetics Revenue Growth Rate in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) Figure 59. Merck Revenue Growth Rate in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) Figure 61. Genmab AS Revenue Growth Rate in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) Figure 62. Takeda Pharmaceutical Revenue Growth Rate in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) Figure 63. Eisai Co., Ltd. Revenue Growth Rate in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) Figure 64. Cellerant Therapeutics Revenue Growth Rate in Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Business (2017-2022) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Roche Novartis Seattle Genetics Merck Bristol-Myers Squibb Genmab AS Takeda Pharmaceutical Eisai Co., Ltd. Cellerant Therapeutics